Barclays lowered the firm’s price target on Keurig Dr Pepper (KDP) to $36 from $39 and keeps an Overweight rating on the shares as part of a
In a report released today, Lauren Lieberman from Barclays maintained a Buy rating on Keurig Dr Pepper (KDP – Research Report), with a price
Dakota Wealth Management lowered its holdings in Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 81.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,478 shares of the company’s stock after selling 80,
With a market cap of $42.3 billion, Keurig Dr Pepper Inc. (KDP) is a leader in beverages and single-serve brewing systems, delivering iconic brands like Dr Pepper, Green Mountain Coffee Roasters, and Snapple across the U.
Keurig Dr Pepper Inc (KDP) stock saw a modest uptick, ending the day at $31.62 which represents a slight increase of $0.34 or 1.09% from the prior close of $31.28. The stock opened at $31.59 and touched a low of $31.
Keurig Dr Pepper Inc. closed 16.77% below its 52-week high of $38.28, which the company reached on September 24th.
Keurig Dr Pepper Inc (KDP) stock saw a modest uptick, ending the day at $31.15 which represents a slight increase of $0.10 or 0.32% from the prior close of $31.05. The stock opened at $31.12 and touched a low of $30.
Keurig Dr Pepper (NASDAQ:KDP – Free Report) had its price objective trimmed by Barclays from $39.00 to $36.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.
This was the stock's second consecutive day of gains.
BURLINGTON, Mass. and FRISCO, Texas, Jan. 23, 2025 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) will release its financial results for the fourth quarter and full year ended December 31 ...
Dividend amount and dividend per share are quoted in the currency of the stock selected. Please note that past performance is not a reliable indicator of future returns. Important Information Please note the value of investments can go down as well as up ...
Finally, Barclays cut their target price on Keurig Dr Pepper from $39.00 to $36.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Six equities ...